Aaron Sato

OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA.

Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA.

LakePharma, Inc. operates as a contract research organization which engages in the provision of antibody and protein engineering, cell line development, and protein production. Its services include antibody generation, antibody engineering and production, protein engineering and production, protein conjugation, protein analytics, bioassays, DNA studio, stable cell lines, bio manufacturing and service packages. The company was founded by Hua Tu in September 2009 and is headquartered in Belmont, CA.

Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA.